CAMPBELL BRADLEY L (President and CEO) sold 1.3% of their position (14.59K shares) of AMICUS THERAPEUTICS, INC. on the open market
Open‑market sale worth $146.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/3/2025ACC: 0001193125-25-307200
DirectorOfficer· President and CEO
Since Mar 2026
-14.59K
Net shares
Net seller
$146.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
14.59K acquired · 29.17K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+14.59K
Price / share
$9.03
Trade value
$131.72K
% of position
1.3%
12/1/2025
1.14M→1.15M
Common Stock
Direct
Shares
−14.59K
Price / share
$10.01
Trade value
$146.01K
% of position
1.3%
12/1/2025
1.15M→1.14M
Total
Net shares
+0.00
Net value
-$14.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/1/2025 | M · Option Exercise | +14.59K | $9.03 | $131.72K | 1.3% | 1.14M | 1.15M |
| Common Stock Direct | 12/1/2025 | S · Sale | −14.59K | $10.01 | $146.01K | 1.3% | 1.15M | 1.14M |
| Total | +0.00 | -$14.29K | ||||||
Derivative Transactions1
Stock Options (right to buy)
Direct
Converts to
Common Stock
14.59K shares
Shares
−14.59K
Strike price
9.03
Held after
70.43K
Exercisable
—
12/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) Direct | Common Stock14.59K shares | 12/1/2025 | M · Option Exercise | −14.59K | 9.03 | — | 70.43K |